在线录制康复叙事改善非精神病性心理健康问题患者生活质量的实效性与成本效果:一项实用性随机对照试验
该实用性平行组随机对照试验评估NEON干预(提供659条录制康复叙事的网络应用)对比常规照护对非精神病性心理健康问题成人生活质量的影响。共纳入1023名参与者,第52周时干预组MANSA生活质量评分较对照组显著提高0.13分(95%CI 0.01-0.26,p=0.041),并在意义存在子量表得分上显著提高0.22分(95%CI 0.05-0.40,p=0.014)。增量成本效果比为每QALY 12526英镑,低于英国NHS的20000英镑/QALY阈值,表明该干预具有成本效果。
要点
- NEON干预第52周显著改善生活质量(MANSA评分差异0.13,95%CI 0.01-0.26)。
- 干预组意义存在子量表得分显著提高0.22分(95%CI 0.05-0.40)。
- 增量成本效果比为每QALY 12526英镑,低于NHS阈值。
核心结论
- NEON干预对经历非精神病性心理健康问题的人群是一种有效且具有成本效果的新干预措施。
研究设计与样本
- 实用性平行组随机对照试验,以常规照护为对照,从英格兰招募1023名非精神病性心理健康问题成人,目标样本量基于功效分析为994。
主要发现
- 第52周意向性治疗分析显示,干预组与对照组MANSA评分基线调整后差异为0.13(95%CI 0.01-0.26,p=0.041),相当于每名参与者平均变化1.56个量表分。
- 第52周意义存在子量表评分基线调整后组间差异为0.22(95%CI 0.05-0.40,p=0.014),相当于每名参与者平均变化1.1个量表分。
- 每名参与者增量获得0.0142个质量调整生命年(QALYs)(95%可信区间0.0059至0.0226),增量成本增加178英镑(95%可信区间-154至455英镑)。
- 增量成本效果比为每QALY 12526英镑,低于英国国家医疗服务体系采用的每QALY 20000英镑阈值。
- 在基线使用专科心理健康服务的参与者亚组中,干预组较对照组每名参与者成本降低98英镑(95%可信区间-606至309英镑)且QALYs改善0.0165(95%可信区间0.0057至0.0273)。
临床怎么用
- 可将NEON干预作为非精神病性心理健康问题患者的辅助手段,以改善生活质量和意义感。
- 该干预具有成本效果,可考虑纳入心理健康服务资源配置。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Narratives describing first-hand experiences of recovery from mental health problems are widely available. Emerging evidence suggests that engaging with mental health recovery narratives can benefit people experiencing mental health problems, but no randomized controlled trial has been conducted as yet. We developed the Narrative Experiences Online (NEON) Intervention, a web application providing self-guided and recommender systems access to a collection of recorded mental health recovery narratives (n=659). We investigated whether NEON Intervention access benefited adults experiencing non-psychotic mental health problems by conducting a pragmatic parallel-group randomized trial, with usual care as control condition. The primary endpoint was quality of life at week 52 assessed by the Manchester Short Assessment (MANSA). Secondary outcomes were psychological distress, hope, self-efficacy, and meaning in life at week 52. Between March 9, 2020 and March 26, 2021, we recruited 1,023 participants from across England (the target based on power analysis was 994), of whom 827 (80.8%) identified as White British, 811 (79.3%) were female, 586 (57.3%) were employed, and 272 (26.6%) were unemployed. Their mean age was 38.4±13.6 years. Mood and/or anxiety disorders (N=626, 61.2%) and stress-related disorders (N=152, 14.9%) were the most common mental health problems. At week 52, our intention-to-treat analysis found a significant baseline-adjusted difference of 0.13 (95% CI: 0.01-0.26, p=0.041) in the MANSA score between the intervention and control groups, corresponding to a mean change of 1.56 scale points per participant, which indicates that the intervention increased quality of life. We also detected a significant baseline-adjusted difference of 0.22 (95% CI: 0.05-0.40, p=0.014) between the groups in the score on the "presence of meaning" subscale of the Meaning in Life Questionnaire, corresponding to a mean change of 1.1 scale points per participant. We found an incremental gain of 0.0142 quality-adjusted life years (QALYs) (95% credible interval: 0.0059 to 0.0226) and a £178 incremental increase in cost (95% credible interval: -£154 to £455) per participant, generating an incremental cost-effectiveness ratio of £12,526 per QALY compared with usual care. This was lower than the £20,000 per QALY threshold used by the National Health Service in England, indicating that the intervention would be a cost-effective use of health service resources. In the subgroup analysis including participants who had used specialist mental health services at baseline, the intervention both reduced cost (-£98, 95% credible interval: -£606 to £309) and improved QALYs (0.0165, 95% credible interval: 0.0057 to 0.0273) per participant as compared to usual care. We conclude that the NEON Intervention is an effective and cost-effective new intervention for people experiencing non-psychotic mental health problems.
引用
- Slade M, Rennick-Egglestone S, Elliott RA, et al. Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with non-psychotic mental health problems: a pragmatic randomized controlled trial. World Psychiatry. 2024. PMID: 38214639. doi:10.1002/wps.21176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。